Keros Therapeutics: clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. We are a leader in understanding the role of the Transforming Growth Factor-Beta family of proteins that is a master regulator of red blood cell and platelet production as well as the growth, repair and maintenance of muscle and bone. Our lead protein therapeutic product candidate, KER-050, is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome and myelofibrosis. Our lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from elevated levels of hepcidin, the key regulator of iron absorption and recycling, as well as for the treatment of fibrodysplasia ossificans progressiva.
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Hematology, Metabolic Disorders, Rare Disease
Public, USA
Market Cap
500MM - 1B
99 Hayden Avenue
Suite 120 (Building E)
Lexington, MA 02421
United States

Top 10 Holders of Keros Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RA Capital Management LLC 9.29 1,875,000 84.73 13F 6/30/20
OrbiMed Advisors LLC 8.33 1,679,417 75.89 13F 6/30/20
Foresite Capital Management IV LLC 7.08 1,428,071 64.53 13F 6/30/20
Fidelity Management & Research Co. LLC 6.74 1,359,672 61.44 13F 6/30/20
Logos Global Management LP 6.72 1,350,000 61.01 Stakes 8/20/20
VR Adviser LLC 3.33 672,306 30.38 13F 6/30/20
CHI Advisors LLC 2.87 579,744 26.20 13F 6/30/20
Invesco Advisers, Inc. 1.49 301,268 13.61 13F 6/30/20
Deerfield Management Company LP 1.49 300,000 13.56 13F 6/30/20
Vanguard Group, Inc. (Subfiler) 1.47 296,472 13.40 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.